U.S. mRNA Therapeutics CDMO Market: By Indication (Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases); Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies); End Use (Biotech Companies, Pharmaceutical Companies, Government & Academic Research Institutes)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025–2033
US mRNA therapeutics CDMO market was valued at US$ 1.78 billion in 2024 and is projected to hit the market valuation of US$ 6.27 billion by 2033 at a CAGR of 15.01% during the forecast period 2025–2033. Read More
- Last Updated: 13-Aug-2025 | Format:
![pdf]()
![powerpoint]()
![excel]()
| Report ID: AA08251447
| Report ID: AA08251447Fill out the form below to receive a free sample of this report
Features | Type of License | ||||
 Data Book | Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 1 User Only | Up to 7 Users | Unlimited User Access | |
⨉ | ⨉ | ⨉ | ✓ | ||
Free Customization | No Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ⨉ | ✓ | ✓ | ✓ |
| ✓ | ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ⨉ | ✓ | |
Analyst Support | 2-Months Analyst Support | 4-Months Analyst Support | 7-Months Analyst Support | One Year Analyst Support | |
Free Report update in next update cycle | ⨉ | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ⨉ | ✓ | |
Benefit | Up to 10% off on Post Purchase | Up to 20% off on Post Purchase | Up to 30% off on Post Purchase | Up to 40% off on Post Purchase | |
